Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius C Hoener

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
British Journal of Pharmacology|March 14, 2015
Pharmacological profile of novel psychoactive benzofuransAnna Rickli, Simone Kopf, Marius C Hoener, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 7, 2015
Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholdsYue Pei, Patrick Mortas, Marius C Hoener, et al.
International Journal of Molecular Sciences|November 9, 2024
Wakefulness Induced by TAAR1 Partial Agonism in Mice Is Mediated Through Dopaminergic NeurotransmissionSunmee Park, Jasmine Heu, Marius C Hoener, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Wakefulness Induced by TAAR1 Partial Agonism is Mediated Through Dopaminergic NeurotransmissionSunmee Park, Jasmine Heu, Marius C Hoener, et al.
International Journal of Molecular Sciences|August 7, 2021
The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone DerivativeKarolina E Kolaczynska, Jan Thomann, Marius C Hoener, et al.
Pharmacology & Therapeutics|July 21, 2017
Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challengesMark D Berry, Raul R Gainetdinov, Marius C Hoener, et al.
Neuro-Degenerative Diseases|August 16, 2006
Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screeningsEvelyn Braungart, Manfred Gerlach, Peter Riederer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 25, 2016
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogensAnna Rickli, Olivier D Moning, Marius C Hoener, et al.
Biochemical Pharmacology|April 15, 2019
Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD useDino Luethi, Marius C Hoener, Stephan Krähenbühl, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 15, 2022
TAAR1 Regulates Purinergic-induced TNF Secretion from Peripheral, But Not CNS-resident, MacrophagesDavid A Barnes, Marius C Hoener, Craig S Moore, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
British Journal of Pharmacology|March 14, 2015
Pharmacological profile of novel psychoactive benzofuransAnna Rickli, Simone Kopf, Marius C Hoener, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 7, 2015
Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholdsYue Pei, Patrick Mortas, Marius C Hoener, et al.
International Journal of Molecular Sciences|November 9, 2024
Wakefulness Induced by TAAR1 Partial Agonism in Mice Is Mediated Through Dopaminergic NeurotransmissionSunmee Park, Jasmine Heu, Marius C Hoener, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Wakefulness Induced by TAAR1 Partial Agonism is Mediated Through Dopaminergic NeurotransmissionSunmee Park, Jasmine Heu, Marius C Hoener, et al.
International Journal of Molecular Sciences|August 7, 2021
The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone DerivativeKarolina E Kolaczynska, Jan Thomann, Marius C Hoener, et al.
Pharmacology & Therapeutics|July 21, 2017
Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challengesMark D Berry, Raul R Gainetdinov, Marius C Hoener, et al.
Neuro-Degenerative Diseases|August 16, 2006
Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screeningsEvelyn Braungart, Manfred Gerlach, Peter Riederer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 25, 2016
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogensAnna Rickli, Olivier D Moning, Marius C Hoener, et al.
Biochemical Pharmacology|April 15, 2019
Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD useDino Luethi, Marius C Hoener, Stephan Krähenbühl, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 15, 2022
TAAR1 Regulates Purinergic-induced TNF Secretion from Peripheral, But Not CNS-resident, MacrophagesDavid A Barnes, Marius C Hoener, Craig S Moore, et al.
Pageof 9